Login / Signup

Histone deacetylase inhibitor givinostat has ameliorative effect in the colitis model.

Cengiz DibekoğluOytun Erbaş
Published in: Acta cirurgica brasileira (2022)
Givinostat, a good protector and regenerator of tissue and an anti-inflammatory agent, may be involved in the treatment of colitis in the future.
Keyphrases
  • histone deacetylase
  • anti inflammatory
  • ulcerative colitis
  • current status
  • combination therapy